Parenteral Nutrition Market - Snapshot
The global parenteral nutrition market is expanding at a rapid pace due to high prevalence and increase in incidence rate of chronic diseases, new product development and commercialization, and rise in number of pre-term birth rates across the globe. In terms of revenue, the global market was valued at US$ 5,299.5 Mn in 2017 and is projected to reach US$ 8,065.5 Mn by 2026, expanding at a CAGR of 4.7% from 2018 to 2026. The global parenteral nutrition market is also driven by a rise in the number of cases of malnutrition and approvals of novel parenteral nutrition combinations across the globe.
Parenteral nutrition is indicated for patients who cannot intake adequate nutrition orally or enterally, or who have a compromised GI track. Parenteral nutrition products include a range of macronutrients such as carbohydrates, amino acids and lipid emulsions, and micronutrients such as vitamins, trace elements, and minerals. The parenteral nutrition market is majorly driven by increase in incidence of chronic diseases such as cancer, Crohn’s diseases, and HIV. Extensive research and development activities by key players to develop new parenteral nutrition products and rising approvals to novel parenteral nutrition components drive the market.
Parenteral nutrition is considered as an essential treatment therapy to provide adequate nutrition support to malnourished patents. Globally, the incidence of malnutrition is rising rapidly due to poor dietary habits in developed countries and high poverty rate in developing regions. For example, according to the World Health Organization, under-nutrition accounts for more than 11% of the global burden of disease and is considered to be number one risk to health, worldwide. The organization also stated that malnutrition contributes around one-third of all child deaths globally. Moreover, the United Nations Children's Fund (UNICEF) estimated that approximately 195 million children (less than five years of age) are affected by malnutrition each year. Of these, around 20 million children suffer from severe acute malnutrition and another 175 million are undernourished. Furthermore, rise in cases of malnutrition among the geriatric population propels the market. According to the National Resource Center on Nutrition, Physical Activity & Aging, around 1 million housebound older people are malnourished every year in North America. The R&D pipeline of leading companies to develop novel parenteral nutrition drugs is expanding significantly, owing to increasing investments. These companies strive to develop advanced or standard nutritional products that safely and sufficiently satisfy nutrition requirements of patients in different clinical conditions. Several companies have successfully received regulatory approvals for novel and effective parenteral nutrition drugs in the last few years.
In terms of type of nutrition, the global parenteral nutrition market has been segmented into carbohydrates, parenteral lipid emulsions, single dose amino acid solutions, trace elements, electrolytes, & minerals, and vitamins. Of all the products available in the global parenteral nutrition market, the single dose amino acid solutions nutrient segment held a significant share of 34.3% of the market in 2017. Research indicates that it is likely to be the leading nutrient segment, as several leading players are introducing unique amino acid-based parenteral nutrition products. The abundant availability of these products is expected to be the main reason for their soaring success during the forecast period. Reports also suggest that the parenteral lipid emulsion nutrient segment is projected to expand at a CAGR of 5.1% between 2018 and 2026.
In terms of region, the global parenteral nutrition market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market by 2026. The high rate of approvals from the U.S. FDA and supportive insurance policies that cover expenditure on parenteral nutrition are expected to maintain the leading position held by the region in the global market during the forecast period. The parenteral nutrition market in North America, comprising the U.S. and Canada, is expected to be driven by the rising number of diabetes and cancer cases. Furthermore, companies are also trying to expand their operations in Canada to gain a stronger foothold, by meeting the unmet needs of patients. The market in Asia Pacific is projected to expand at a prominent CAGR during the forecast period. Increase in awareness about parenteral nutrition, rapidly changing health care infrastructure in developing countries, such as China and India, and well-established pharmaceutical market in Japan are anticipated to fuel the parenteral nutrition market in Asia Pacific during the forecast period.
Majority of companies have made significant investments in the clinical research and development of parenteral nutrition products. New product development and commercialization among leading players has been a key trend in the global market in the last few years. Key players operating in the global parenteral nutrition market include Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, and Pfizer, Inc.
Parenteral Nutrition Market - Overview
This report by Transparency Market Research analyses the global parenteral nutrition market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment various medical conditions.
The global parenteral nutrition market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global parenteral nutrition market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global parenteral nutrition market for 2017. The report also provides detailed company profiles of emerging market players operating in the global parenteral nutrition market.
The market overview section comprises impact factors such as key market dynamics, including drivers, restraints, and opportunities, affecting the global parenteral nutrition market. These factors are likely to aid stakeholders establish a strong foothold in the global parenteral nutrition market. Furthermore, the market overview section comprises key industry events, pipeline analysis, epidemiology analysis of the inflammatory bowel disease, cancer, and pre-term birth rates, product portfolio overview of leading players, and market attractiveness analysis in the global parenteral nutrition market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.
The global parenteral nutrition market has been segmented based on type of nutrition and region. In terms of type of nutrition, the global market has been classified into carbohydrates, parenteral lipid emulsions, single dose amino acid solutions, trace elements, electrolytes, & minerals, and vitamins.
In terms of region, the global parenteral nutrition market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global market in various regions has been provided in this section.
The report provides a detailed outline/blueprint of the global parenteral nutrition market, which is expected to assist new companies establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.
Major players operating in the global parenteral nutrition market include Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius Kabi AG, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, and Pfizer, Inc.
The global parenteral nutrition market has been segmented into:
Type of Nutrition